Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from CERo Therapeutics Holdings ( (CERO) ).
On October 16, 2025, CERo Therapeutics Holdings, Inc. and its investors amended their Securities Purchase Agreement to include an additional buyer, increasing the initial closing size by $500,000 to approximately $2.25 million, while maintaining the overall funding target of $7 million. The company successfully completed the initial closing with the issuance of 3,816 shares of Series E Preferred Stock, raising $2.25 million, with the remaining $4.75 million to be funded in future closings. The transaction was conducted as a private offering under exemptions from the Securities Act.
The most recent analyst rating on (CERO) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on CERo Therapeutics Holdings stock, see the CERO Stock Forecast page.
More about CERo Therapeutics Holdings
Average Trading Volume: 199,689
Technical Sentiment Signal: Sell
Current Market Cap: $3.13M
Learn more about CERO stock on TipRanks’ Stock Analysis page.